Skip to content
Home/Companies/Biotech/RNAlead
RNAlead

RNAlead

Biotech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns RNAlead?

RNAlead is a French Biotech company, currently owned by TechLife Capital since 2021.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
TechLife Capital
Investor
TechLife Capital
TechLife Capital I · 2018 · Growth

Key facts

HQFrance
SectorBiotech
Websiternalead.com

More from TechLife Capital I

Other portfolio companies in the same fund.

XPath
XPath
Active
HealthcareFrance· 2021
CNSI
Active
TMTFrance· 2020
Maxxing
Maxxing
Exited 2025
SaaSFrance· 2020
to Optimix Solutions
MDT
Active
TMTFrance· 2020
MITEM Pharma
MITEM Pharma
Active
PharmaFrance· 2020
Venn
Active
TMTFrance· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns RNAlead?

RNAlead is currently owned by TechLife Capital, through TechLife Capital I, since 2021.

When did TechLife Capital acquire RNAlead?

TechLife Capital acquired RNAlead in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue